Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
g9W8xeJgf6F69gNb